Ebola cases in Democratic Republic of the Congo surpass 7,000
The Bundibugyo strain has reached a seventh province following a death in South-Ubangi, as transmission accelerates in North Kivu.
The Ebola outbreak in the Democratic Republic of the Congo has surpassed 7,000 confirmed cases and 3,300 deaths, according to the latest reports from the National Institute of Public Health [1, 2]. The epidemic has expanded into a seventh province, South-Ubangi, following the death of a 23-year-old man who had traveled through several other provinces [1, 3]. While the outbreak originated in Ituri, health authorities are seeing a sharp rise in new infections in North Kivu, where treatment centers are currently operating at over 140% capacity [1, 3].
Expansion of the Ebola epidemic
The virus has reached the northwestern province of South-Ubangi, marking the seventh province to be affected by this Bundibugyo strain outbreak [1, 2]. Acting Governor Jean-Rene Galekwa Vundawe reported that the deceased patient had traveled from South-Kivu and through Tshopo province before dying in the Bulu health zone [1, 3]. Officials noted that the patient’s travel route, which included transit by boat on the Congo River through Mongala province, potentially exposes populations in North-Ubangi, Tshopo, and Mongala [3]. Contact tracing is currently underway for 38 people identified as having been in contact with the deceased [3].
Although Ituri remains the epicenter, accounting for nearly 79% of all confirmed cases, the momentum of the outbreak is shifting [1]. The Africa Centres for Disease Control and Prevention (Africa CDC) warned that the virus is spreading rapidly beyond the initial epicenter [3]. In North Kivu, new infections are rising sharply, accounting for more than half of all new cases recorded in a single 24-hour period [1]. This surge has placed immense pressure on local healthcare infrastructure; in North Kivu, the occupancy rate for Ebola treatment centers has reached 141.4% [1].
The scale of the crisis is significant, with the current death toll reaching 3,398 and a case fatality rate of 48.4% [1]. The outbreak is particularly difficult to contain because the Bundibugyo strain lacks an approved vaccine or specific treatment [2]. In Ituri, the return of children to school following summer holidays has caused alarm among parents and health workers due to confirmed cases among students [2].
Research and vaccine developments
A phase 4 clinical trial in Uganda has provided new data regarding yellow fever vaccine administration [5]. The study found that fractional doses of the 17DD yellow fever vaccine, specifically one-fifth and one-half doses, were non-inferior to full doses in inducing initial seroconversion in children aged 9 to 23 months [5]. These results suggest that fractional dosing is a viable strategy for maintaining immunity during outbreak responses when vaccine supplies are limited [5].
References
- RDC : l’épidémie d’Ebola franchit la barre des 7 000 cas et s’étend à une septième province (actualite_cd) — claim_class: news_report; via: Actualité.cd — DRC
- DR Congo’s worst Ebola epidemic ever passes 7,000 cases (aljazeera) — claim_class: news_report; via: Al Jazeera
- DR Congo’s Ebola outbreak spreads to 7th province as cases, deaths mount (cidrap) — claim_class: surveillance_report; via: CIDRAP — Center for Infectious Disease Research and Policy
- [Articles] Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial (thelancet) — claim_class: peer_reviewed; via: The Lancet